{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:14:55Z","timestamp":1791346495381,"version":"4.3.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003662","name":"Korea Evaluation Institute of Industrial Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60739-9","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:34:14Z","timestamp":1783100054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Toward accessible mRNA LNP formulation: systematic evaluation of mixing strategies and key parameters"],"prefix":"10.1038","volume":"16","author":[{"given":"Han Na","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghak","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiwoo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaewon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haena","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Jun","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"60739_CR1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","volume":"23","author":"N Pardi","year":"2024","unstructured":"Pardi, N. & Krammer, F. mRNA vaccines for infectious diseases \u2014 advances, challenges and opportunities. Nat. Rev. Drug Discovery. 23, 838\u2013861. https:\/\/doi.org\/10.1038\/s41573-024-01042-y (2024).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"60739_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discovery. 20, 817\u2013838. https:\/\/doi.org\/10.1038\/s41573-021-00283-5 (2021).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"60739_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","volume":"20","author":"L Miao","year":"2021","unstructured":"Miao, L., Zhang, Y. & Huang, L. mRNA vaccine for cancer immunotherapy. Mol. Cancer. 20, 41. https:\/\/doi.org\/10.1186\/s12943-021-01335-5 (2021).","journal-title":"Mol. Cancer"},{"key":"60739_CR4","doi-asserted-by":"publisher","first-page":"2303261","DOI":"10.1002\/adma.202303261","volume":"35","author":"Y Zong","year":"2023","unstructured":"Zong, Y., Lin, Y., Wei, T. & Cheng, Q. Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy. Adv. Mater. 35, 2303261. https:\/\/doi.org\/10.1002\/adma.202303261 (2023).","journal-title":"Adv. Mater."},{"key":"60739_CR5","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","volume":"17","author":"MA Oberli","year":"2017","unstructured":"Oberli, M. A. et al. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 17, 1326\u20131335. https:\/\/doi.org\/10.1021\/acs.nanolett.6b03329 (2017).","journal-title":"Nano Lett."},{"key":"60739_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"MD Kazatchkine","year":"2001","unstructured":"Kazatchkine, M. D. & Kaveri, S. V. Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin. N. Engl. J. Med. 345, 747\u2013755. https:\/\/doi.org\/10.1056\/NEJMra993360 (2001).","journal-title":"N. Engl. J. Med."},{"key":"60739_CR7","first-page":"7","volume":"3","author":"P Saroj","year":"2012","unstructured":"Saroj, P., Verma, M., Jha, K. K. & pal, M. An overview on immunomodulation. J. Adv. Sci. Res. 3, 7\u201312 (2012).","journal-title":"J. Adv. Sci. Res."},{"key":"60739_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cyto.2017.04.012","volume":"98","author":"EY Kim","year":"2017","unstructured":"Kim, E. Y. & Moudgil, K. D. Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines. Cytokine 98, 87\u201396. https:\/\/doi.org\/10.1016\/j.cyto.2017.04.012 (2017). https:\/\/doi.org\/https:\/\/doi.org\/","journal-title":"Cytokine"},{"key":"60739_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320. https:\/\/doi.org\/10.1038\/s41565-020-0669-6 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"60739_CR10","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1021\/acs.nanolett.7b02664","volume":"17","author":"S Patel","year":"2017","unstructured":"Patel, S. et al. Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA. Nano Lett. 17, 5711\u20135718. https:\/\/doi.org\/10.1021\/acs.nanolett.7b02664 (2017).","journal-title":"Nano Lett."},{"key":"60739_CR11","doi-asserted-by":"publisher","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","volume":"16","author":"J Kim","year":"2022","unstructured":"Kim, J. et al. Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation. ACS Nano. 16, 14792\u201314806. https:\/\/doi.org\/10.1021\/acsnano.2c05647 (2022).","journal-title":"ACS Nano"},{"key":"60739_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","volume":"595","author":"U Sahin","year":"2021","unstructured":"Sahin, U. et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature 595, 572\u2013577. https:\/\/doi.org\/10.1038\/s41586-021-03653-6 (2021).","journal-title":"Nature"},{"key":"60739_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines \u2014 a new era in vaccinology. Nat. Rev. Drug Discovery. 17, 261\u2013279. https:\/\/doi.org\/10.1038\/nrd.2017.243 (2018).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"60739_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.201700375","volume":"2","author":"MJW Evers","year":"2018","unstructured":"Evers, M. J. W. et al. State-of-the-art design and rapid-mixing production techniques of lipid nanoparticles for nucleic acid delivery. Small Methods 2, 1700375. https:\/\/doi.org\/10.1002\/smtd.201700375 (2018).","journal-title":"Small Methods"},{"key":"60739_CR15","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.7150\/thno.77259","volume":"12","author":"HN Jung","year":"2022","unstructured":"Jung, H. N., Lee, S. Y., Lee, S., Youn, H. & Im, H. J. Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging. Theranostics 12, 7509\u20137531. https:\/\/doi.org\/10.7150\/thno.77259 (2022).","journal-title":"Theranostics"},{"key":"60739_CR16","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1021\/acs.molpharmaceut.3c00390","volume":"20","author":"MN O\u2019Brien Laramy","year":"2023","unstructured":"O\u2019Brien Laramy, M. N. et al. Process Robustness in Lipid Nanoparticle Production: A Comparison of Microfluidic and Turbulent Jet Mixing. Mol. Pharm. 20, 4285\u20134296. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00390 (2023).","journal-title":"Mol. Pharm."},{"key":"60739_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202203669","volume":"32","author":"AR Ferhan","year":"2022","unstructured":"Ferhan, A. R. et al. Lipid nanoparticle technologies for nucleic acid delivery: A nanoarchitectonics perspective. Adv. Funct. Mater. 32, 2203669. https:\/\/doi.org\/10.1002\/adfm.202203669 (2022).","journal-title":"Adv. Funct. Mater."},{"key":"60739_CR18","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1021\/acs.langmuir.0c03039","volume":"37","author":"T Terada","year":"2021","unstructured":"Terada, T. et al. Characterization of lipid nanoparticles containing ionizable cationic lipids using design-of-experiments approach. Langmuir 37, 1120\u20131128. https:\/\/doi.org\/10.1021\/acs.langmuir.0c03039 (2021).","journal-title":"Langmuir"},{"key":"60739_CR19","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","volume":"119","author":"AK Leung","year":"2015","unstructured":"Leung, A. K., Tam, Y. Y., Chen, S., Hafez, I. M. & Cullis, P. R. Microfluidic mixing: A general method for encapsulating macromolecules in lipid nanoparticle systems. J. Phys. Chem. B 119, 8698\u20138706. https:\/\/doi.org\/10.1021\/acs.jpcb.5b02891 (2015).","journal-title":"J. Phys. Chem. B"},{"key":"60739_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12111095","author":"CB Roces","year":"2020","unstructured":"Roces, C. B. et al. Manufacturing considerations for the development of lipid nanoparticles using microfluidics. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics12111095 (2020).","journal-title":"Pharmaceutics"},{"key":"60739_CR21","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1021\/acs.nanolett.1c01353","volume":"21","author":"SJ Shepherd","year":"2021","unstructured":"Shepherd, S. J. et al. Scalable mRNA and siRNA lipid nanoparticle production using a parallelized microfluidic device. Nano Lett. 21, 5671\u20135680. https:\/\/doi.org\/10.1021\/acs.nanolett.1c01353 (2021).","journal-title":"Nano Lett."},{"key":"60739_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","volume":"344","author":"M Maeki","year":"2022","unstructured":"Maeki, M., Uno, S., Niwa, A., Okada, Y. & Tokeshi, M. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery. J. Control. Release 344, 80\u201396. https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.017 (2022).","journal-title":"J. Control. Release"},{"key":"60739_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2023.100161","volume":"12","author":"DC J\u00fcrgens","year":"2023","unstructured":"J\u00fcrgens, D. C. et al. Lab-scale siRNA and mRNA LNP manufacturing by various microfluidic mixing techniques \u2013 An evaluation of particle properties and efficiency. OpenNano 12, 100161 (2023).","journal-title":"OpenNano"},{"key":"60739_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401252","volume":"13","author":"D Bi","year":"2024","unstructured":"Bi, D. et al. On the influence of fabrication methods and materials for mRNA-LNP production: From size and morphology to internal structure and mRNA delivery performance in vitro and in vivo. Adv. Healthc. Mater. 13, 2401252. https:\/\/doi.org\/10.1002\/adhm.202401252 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"60739_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13112-5","volume":"12","author":"M Ripoll","year":"2022","unstructured":"Ripoll, M. et al. Optimal self-assembly of lipid nanoparticles (LNP) in a ring micromixer. Sci. Rep. 12, 9483. https:\/\/doi.org\/10.1038\/s41598-022-13112-5 (2022).","journal-title":"Sci. Rep."},{"key":"60739_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","volume":"335","author":"KJ Hassett","year":"2021","unstructured":"Hassett, K. J. et al. Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. J. Control. Release 335, 237\u2013246. https:\/\/doi.org\/10.1016\/j.jconrel.2021.05.021 (2021).","journal-title":"J. Control. Release"},{"key":"60739_CR27","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1021\/acsomega.8b00341","volume":"3","author":"N Kimura","year":"2018","unstructured":"Kimura, N. et al. Development of the iLiNP device: Fine tuning the lipid nanoparticle size within 10 nm for drug delivery. ACS Omega 3, 5044\u20135051. https:\/\/doi.org\/10.1021\/acsomega.8b00341 (2018).","journal-title":"ACS Omega"},{"key":"60739_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.actbio.2018.09.047","volume":"81","author":"Z He","year":"2018","unstructured":"He, Z. et al. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery. Acta Biomater. 81, 195\u2013207. https:\/\/doi.org\/10.1016\/j.actbio.2018.09.047 (2018).","journal-title":"Acta Biomater."},{"key":"60739_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.nantod.2016.04.006","volume":"11","author":"W Saad","year":"2016","unstructured":"Saad, W. Prud\u2019homme, R. Principles of nanoparticle formation by Flash Nanoprecipitation. Nano Today 11, 212\u2013227. https:\/\/doi.org\/10.1016\/j.nantod.2016.04.006 (2016).","journal-title":"Nano Today"},{"key":"60739_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.apsb.2018.11.001","volume":"9","author":"J Tao","year":"2019","unstructured":"Tao, J., Chow, S. F. & Zheng, Y. Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles. Acta Pharm. Sinica B. 9, 4\u201318. https:\/\/doi.org\/10.1016\/j.apsb.2018.11.001 (2019).","journal-title":"Acta Pharm. Sinica B"},{"key":"60739_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33157-4","volume":"13","author":"S Li","year":"2022","unstructured":"Li, S. et al. Payload distribution and capacity of mRNA lipid nanoparticles. Nat. Commun. 13, 5561. https:\/\/doi.org\/10.1038\/s41467-022-33157-4 (2022).","journal-title":"Nat. Commun."},{"key":"60739_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.colsurfb.2015.12.023","volume":"140","author":"J Gu","year":"2016","unstructured":"Gu, J., Hao, J., Fang, X. & Sha, X. Factors influencing the transfection efficiency and cellular uptake mechanisms of Pluronic P123-modified polypropyleneimine\/pDNA polyplexes in multidrug resistant breast cancer cells. Colloids Surf. B Biointerfaces 140, 83\u201393. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.12.023 (2016).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"60739_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.actbio.2021.06.023","volume":"131","author":"EH Pilkington","year":"2021","unstructured":"Pilkington, E. H. et al. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 131, 16\u201340. https:\/\/doi.org\/10.1016\/j.actbio.2021.06.023 (2021).","journal-title":"Acta Biomater."},{"key":"60739_CR34","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","volume":"13","author":"JA Kulkarni","year":"2017","unstructured":"Kulkarni, J. A. et al. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomedicine 13, 1377\u20131387. https:\/\/doi.org\/10.1016\/j.nano.2016.12.014 (2017).","journal-title":"Nanomedicine"},{"key":"60739_CR35","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1021\/acsnano.8b07858","volume":"13","author":"J Buck","year":"2019","unstructured":"Buck, J. et al. Therapeutics: Hallmarks of Non-Viral Gene Delivery. ACS Nano. 13, 3754\u20133782. https:\/\/doi.org\/10.1021\/acsnano.8b07858 (2019).","journal-title":"ACS Nano"},{"key":"60739_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jconrel.2011.11.014","volume":"161","author":"C Scholz","year":"2012","unstructured":"Scholz, C. & Wagner, E. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. J. Control Release. 161, 554\u2013565. https:\/\/doi.org\/10.1016\/j.jconrel.2011.11.014 (2012).","journal-title":"J. Control Release"},{"key":"60739_CR37","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1038\/s41467-022-31993-y","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Multi-step screening of DNA\/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression. Nat. Commun. 13, 4282. https:\/\/doi.org\/10.1038\/s41467-022-31993-y (2022).","journal-title":"Nat. Commun."},{"key":"60739_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.addr.2017.12.015","volume":"128","author":"X Li","year":"2018","unstructured":"Li, X. & Jiang, X. Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles. Adv. Drug Deliv. Rev. 128, 101\u2013114. https:\/\/doi.org\/10.1016\/j.addr.2017.12.015 (2018). https:\/\/doi.org\/https:\/\/doi.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"60739_CR39","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1039\/B923299K","volume":"6","author":"JM Zook","year":"2010","unstructured":"Zook, J. M. & Vreeland, W. N. Effects of temperature, acyl chain length, and flow-rate ratio on liposome formation and size in a microfluidic hydrodynamic focusing device. Soft Matter. 6, 1352\u20131360. https:\/\/doi.org\/10.1039\/B923299K (2010).","journal-title":"Soft Matter"},{"key":"60739_CR40","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1021\/nn901433u","volume":"4","author":"PM Valencia","year":"2010","unstructured":"Valencia, P. M. et al. Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano. 4, 1671\u20131679. https:\/\/doi.org\/10.1021\/nn901433u (2010).","journal-title":"ACS Nano"},{"key":"60739_CR41","doi-asserted-by":"publisher","first-page":"122320","DOI":"10.1016\/j.ijpharm.2022.122320","volume":"628","author":"E Jaradat","year":"2022","unstructured":"Jaradat, E., Weaver, E., Meziane, A. & Lamprou, D. A. Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy. Int. J. Pharm. 628, 122320. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122320 (2022).","journal-title":"Int. J. Pharm."},{"key":"60739_CR42","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","volume":"31","author":"C He","year":"2010","unstructured":"He, C., Hu, Y., Yin, L., Tang, C. & Yin, C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31, 3657\u20133666. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.01.065 (2010).","journal-title":"Biomaterials"},{"key":"60739_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s11671-018-2728-6","volume":"13","author":"P Foroozandeh","year":"2018","unstructured":"Foroozandeh, P. & Aziz, A. A. Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles. Nanoscale Res. Lett. 13, 339. https:\/\/doi.org\/10.1186\/s11671-018-2728-6 (2018).","journal-title":"Nanoscale Res. Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60739-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:08:09Z","timestamp":1790899689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60739-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60739"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60739-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.\u00a0Hyung-Jun Im is a co-founder and Chief Scientific Officer of Portrai.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures and ethics in animal research was approved by Seoul National University Institutional Animal Care and Use Committee (IACUC) and were conducted in complied with the ARRIVE guidelines 2.0.","order":2,"name":"Ethics","label":"Ethics\u00a0","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30643"}}